Company profile
Quoin Pharmaceuticals, Ltd.
NASDAQ:QNRXBiotechnology: Pharmaceutical Preparations
Clinical trials (4)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT06953466 | phase2_3 | recruiting | 2025-10-06 | 2026-12-30 | Quoin Pharmaceuticals | Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome |
| NCT05789056 | phase2_3 | recruiting | 2023-03-14 | 2026-12-30 | Quoin Pharmaceuticals | Open Label, Safety and Efficacy Study of QRX003 Lotion in Subjects With Netherton Syndrome |
| NCT07538583 | phase2_3 | recruiting | 2026-03-19 | 2027-01-31 | Quoin Pharmaceuticals | Phase 2/3 Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome |
| NCT05521438 | phase2_3 | active_not_recruiting | 2022-06-23 | 2025-12-30 | Quoin Pharmaceuticals | Safety, Tolerability and Efficacy of QRX003 Lotion in Subjects With Netherton Syndrome |
FDA applications (0)
No records yet.